New website is here!
Create an account to use the new features. Feel free to leave us feedback, constructive criticism welcome!
EMV's Principal Activity is the research and development of medical imaging and diagnostic technology previously licensed and subsequently acquired from Uniquest Pty Limited (Uniquest) (the EMVision Technology), for the purpose of commercialising a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||+258.81%|
|vs ASX 200 (1yr)||+253.68%|
|ASX Rank||678 of 2,466|
|Sector Rank||52 of 177|
EMvision Medical Devices Limited (EMV) is focused on the development and commercialisation of medical imaging technology. The Company is developing and seeking to commercialise a cost effective, portable, medical imaging device using electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications.
No incorporation details available.
|No dividends paid.|
See Upcoming Dividends for all ASX companies.
|Dr Phillip James Dubois||Non-Executive Director||Sep 2020||
Dr Phillip James Dubois
Dr Dubois is Non-executive Director of Sonic Healthcare (ASX:SHL), former CEO of their imaging division and served as Executive Director from 2001 to 2020. He is also the founder and former CEO and Chairman of Queensland X-Ray. Dr Dubois is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association. Dr Dubois is a Non-executive Director of Magnetica Limited.
|Dr Ronald (Ron) Peter Weinberger||Chief Executive Officer, Managing Director||May 2020||
Dr Ronald (Ron) Peter Weinberger
Chief Executive Officer, Managing Director
Dr Weinberger has more than 20 years' experience in medical research, biotechnology and commercialization. Dr Weinberger joined Nanosonics in August 2004 and was appointed as Executive Director in July 2008 then Managing Director and Chief Executive Officer December 2011 with a period as acting CEO from May 2011. From October 2013 to February 2018, Dr Weinberger was responsible for the direction of Nanosonics' technology development and commercialisation strategy. He is co-inventor of several of Nanosonics' technology patents.
|Mr Anthony (Tony) Keane||Non-Executive Director||Jun 2018||
Mr Anthony (Tony) Keane
Mr Keane is an experienced business and finance executive and holds a number of independent non-executive director and advisory board roles. Mr Keane also undertakes finance advisory and consultancy assignments for various business clients and previously held roles with trading bank principally in business, corporate and institutional banking. Mr Keane is currently an Independent Non-Executive Director of National Storage Holdings Ltd, the holding company established for National Storage REIT, and director of Queensland Symphony Orchestra Holdings Ltd. He is Chair of Risk Committee.
|Mr John Keep||Non-Executive Chairman, Non-Executive Director||Mar 2018||
Mr John Keep
Non-Executive Chairman, Non-Executive Director
Mr Keep has public company board experience as well as senior management experience in the healthcare and hospitality sectors including managing start up enterprises and medical diagnostic companies. Mr Keep led the restructuring and revitalization of the radiology company Queensland Diagnostic Imaging and at Lemarne Healthcare. Mr Keep is a director of Queensland Symphony Orchestra Holdings Ltd and a member of that company's Finance Audit and Risk Committee. He is Member of Risk Committee.
|Mr Geoffrey (Geoff) Richard Pocock||Non-Executive Director||Mar 2018||
Mr Geoffrey (Geoff) Richard Pocock
Mr Pocock has experience as a corporate advisor and strategy consultant advising companies on commercialisation and IP management, business development, mergers and acquisitions strategy and raising equity capital from private and public equity markets. Mr Pocock is currently the principal of Polaris Consulting (WA) Pty Ltd. He is Member of Risk Committee.
|Mr Scott Kirkland||Co-founder, Executive Director||Jul 2017||
Mr Scott Kirkland
Co-founder, Executive Director
Mr Kirkland has held several senior sales positions, including Head of Client Sales at Quantcast. Mr Kirkland is a co-founder of the Company and oversees its corporate affairs, commercial strategy and business development efforts.
EMV directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
|07/12/20||Phillip Dubois||Issued||500,000||$3.34||$1,670,000||Issue of options|
|07/12/20||Ronald (Ron) Weinberger||Issued||1,000,000||$3.34||$3,340,000||Issue of options|
|01/12/20||Geoffrey (Geoff) Pocock||Buy||+5,000||$3.30||$16,500||On-market trade|
|01/10/20||Phillip Dubois||Buy||+40,000||$2.50||$100,000||Off-market trade|
|01/10/20||Phillip Dubois||Buy||+40,000||$2.50||$100,000||Off-market trade|
|04/06/19||Ryan Laws||Buy||+14,844||$0.38||$5,641||On-market trade|
|03/06/19||Ryan Laws||Buy||+15,156||$0.368||$5,582||On-market trade|
|21/12/18||Scott Kirkland||Buy||+17,766||$0.304||$5,401||On-market trade|
|20/12/18||Scott Kirkland||Buy||+35,634||$0.303||$10,797||On-market trade|
|19/12/18||Geoffrey (Geoff) Pocock||Buy||+50,000||$0.301||$15,041||On-market trade|
|19/12/18||Ryan Laws||Buy||+70,000||$0.303||$21,180||On-market trade|
|18/12/18||Geoffrey (Geoff) Pocock||Buy||+35,000||$0.304||$10,630||On-market trade|
The current holdings of EMV directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
|Ronald (Ron) Weinberger||07/12/2020||1,000,000||20,000||2,000,000||N/A|
|Geoffrey (Geoff) Pocock||01/12/2020||N/A||355,000||500,000||N/A|
|Anthony (Tony) Keane||30/06/2020||100,000||N/A||500,000||N/A|
Data supplied by Morningstar and accurate on Aug 24, 2020.
It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.
All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).
|Uniquest Pty Ltd||6,000,000||8.55%|
|Mr Scott Philip Kirkland||3,333,400||4.75%|
|Ryan Michael Laws||3,212,500||4.58%|
|Glensburg Pty Ltd||1,100,000||1.57%|
|Walsh Prestige Pty Ltd||1,040,000||1.48%|
|Mr Bryant James Mclarty||1,023,688||1.46%|
|Mr Martin Kolev||1,000,000||1.42%|
|Dr Stuart Crozier||1,000,000||1.42%|
|Kong Pak Lim||939,500||1.34%|
|Hillridge Pty Ltd||900,000||1.28%|
|Wakil Family Group Pty Ltd||840,437||1.20%|
|Mr Paul Raymond Brown & Mrs Angelique Susan Brown||827,277||1.18%|
|Bellcoo Investments Pty Ltd||770,000||1.10%|
|Neweconomy Com Au Nominees Pty Limited||758,288||1.08%|
|Macequest Pty Limited||741,298||1.06%|
|Jm Starcevich Investments Pty Ltd||696,660||0.99%|
|Ross D Smith Investments Pty Ltd||696,084||0.99%|
|Forza Management Pty Ltd||672,500||0.96%|
|Shah Nominees Pty Ltd||625,000||0.89%|
|John Keep & Sons Pty Ltd||607,500||0.86%|
|Mrs Carol Anne Kirkland||539,350||0.77%|
|Holding Size||1 - 1,000||1,001 - 5,000||5,001 - 10,000||10,001 - 100,000||100,001+||Total|
|No. of Shareholders||396||715||342||537||108||2,098|
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held under multiple names so the Substantial Shareholders list differs from the Top 20 Shareholders list.
|Name||Last Notice||Total Shares||Shares Held (%)|
|Date||Name||Bought||Previous %||New %|
|Date||Name||Sold||Previous %||New %|
|16-12-20||UniQuest pty Ltd||--||8.55||--|
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.